Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions-Reference-Cited by-同舟云学术

Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions

Published:2018-08 Issue: Volume:236 Page:291-297
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Riva-Posse Patricio,Reiff Collin M.,Edwards Johnathan A.,Job Gregory P.,Galendez Gail C.,Garlow Steven J.,Saah Tammy C.,Dunlop Boadie W.,McDonald William M.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference28 articles.

1. Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action;Andrade;J. Clin. Psychiatry,2017

2. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety;Ballard;J. Psychiatr. Res.,2014

3. Antidepressant effects of ketamine in depressed patients;Berman;Biol. Psychiatry,2000

4. Barriers to care-seeking for depressed African Americans;Cruz;Int. J. Psychiatry Med.,2008

5. Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression;George;Am. J. Geriatr. Psychiatry: Off. J. Am. Assoc. Geriatr. Psychiatry,2017

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood pressure changes during ketamine infusion for the treatment of depression;General Hospital Psychiatry;2024-09

2. Adjuvant Analgesics in Acute Pain – Evaluation of Efficacy;Current Pain and Headache Reports;2024-06-12

3. Effect of Continuous Infusion of Different Doses of Esketamine on the Bispectral Index During Sevoflurane Anesthesia: A Randomized Controlled Trial;Drug Design, Development and Therapy;2024-05

4. Ketamine induces multiple individually distinct whole-brain functional connectivity signatures;eLife;2024-04-17

5. The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models;Psychopharmacology;2023-06-13